Table 1.
Studies on the association of ALDH1B1 with cancer.
| Type of Cancer | Techniques Used | Samples Used | Ref. |
|---|---|---|---|
| Colorectal Cancer | Computational analysis | Colon and rectum adenocarcinoma (TCGA samples) | [202] |
| Western blot/Flow cytometry/PCR/Comet assay | Cell line/TCGA samples | [134] | |
| shRNA/Immunoblot/qPCR | Cell line | [203] | |
| Immunohistochemistry/Computational analysis | Patient and tissue samples | [204] | |
| Macroscopic evaluation/Immunohistochemistry | Xenografts | [205] | |
| shRNA/Western blot | Cell lines | [145] | |
| qPCR/Western blot/Flow Cytometry | Cell line | [146] | |
| qPCR/Western blot/Aldefluor assay | Cell lines/Tissue | [206] | |
| Immunohistochemistry | Tisue | [192] | |
| Colorectal Tissue Micro Array/Immunohistochemistry | Patients | [207] | |
| p53 lentiviral shRNA | Colon cancer stem cells | [208] | |
| Pancreatic Cancer | FACS/Immunofluorescence | In vivo | [209] |
| shRNA/Immunohistochemistry/RT-PCR | Cell lines/Tissue | [153] | |
| Osteosarcoma | siRNA/Flow cytometry/Western blot | Osteosarcoma patients/Cell lines/In vivo | [162] |
| Nasopharyngeal Carcinoma (NPC) | Immunohistochemistry/Bioinformatic analysis | Patients | [158] |
| Hepatocellular Carcinoma | Kaplan–Meier survival analysis | Patients | [210] |
| Gastric Cancer | Kaplan–Meier survival analysis | Patients | [211] |
| qPCR | MKN-45, SGC-7901 and MKN-45, SGC-7901 spheres | [160] | |
| Prostate cancer | SNPs | Prostate cancer patients | [212] |
| Esophageal Squamous Cell Carcinoma (ESCC) | Computational analysis | Patients | [213] |
| Lung Adenocarcinoma/Lung Squamous Cell Carcinoma | Computational analysis | Lung adenocarcinoma/Lung Squamous Cell Carcinoma (TCGA samples) | [202] |
| Flow cytometry/Western blot/qPCR | Cell line | [214] | |
| Breast Cancer | Computational analysis | Breast cancer (TCGA samples) | [202] |
| RNA-seq/survival data | Breast cancer patients(TCGA) | [215] | |
| Glioblastoma | Computational analysis | Glioblastoma (TCGA samples) | [202] |